Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Esperion Theraptc (ESPR)

Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 398,337
  • Shares Outstanding, K 196,225
  • Annual Sales, $ 116,330 K
  • Annual Income, $ -209,250 K
  • EBIT $ 5 M
  • EBITDA $ 6 M
  • 60-Month Beta 0.95
  • Price/Sales 3.44
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 103.25% ( -7.13%)
  • Historical Volatility 66.82%
  • IV Percentile 31%
  • IV Rank 17.66%
  • IV High 393.52% on 09/20/24
  • IV Low 40.97% on 06/13/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 952
  • Volume Avg (30-Day) 1,146
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 101,191
  • Open Int (30-Day) 98,015

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.14
  • Number of Estimates 5
  • High Estimate -0.06
  • Low Estimate -0.21
  • Prior Year -0.37
  • Growth Rate Est. (year over year) +62.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.82 +9.89%
on 10/10/24
2.26 -11.50%
on 10/28/24
-0.16 (-7.41%)
since 10/04/24
3-Month
1.58 +26.58%
on 10/02/24
2.26 -11.50%
on 10/28/24
-0.06 (-2.91%)
since 08/02/24
52-Week
0.87 +131.21%
on 11/10/23
3.40 -41.18%
on 04/08/24
+0.97 (+94.17%)
since 11/03/23

Most Recent Stories

More News
Esperion to Participate in Upcoming Jefferies London Healthcare Conference

ESPR : 2.00 (-1.48%)
Esperion Announces a Featured Presentation in the Late Breaker/Featured Science Track and Three Poster Presentations Accepted for the 2024 American Heart Association (AHA) Scientific Sessions

ESPR : 2.00 (-1.48%)
Esperion to Report Third Quarter 2024 Financial Results on November 7

ESPR : 2.00 (-1.48%)
Esperion Therapeutics: Q2 Earnings Snapshot

Esperion Therapeutics: Q2 Earnings Snapshot

ESPR : 2.00 (-1.48%)
Stocks Climb Before the Open as Investors Await U.S. Economic Data, BoE Decision in Focus

June S&P 500 E-Mini futures (ESM24) are up +0.37%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.62% this morning as trading resumed after the Juneteenth holiday, with investors looking ahead to...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
NVDA : 136.05 (+0.48%)
MU : 101.73 (+2.01%)
SILK : 27.49 (-0.04%)
LEN : 172.63 (+1.75%)
ACN : 343.90 (-0.51%)
KR : 56.27 (-0.53%)
DRI : 158.77 (-0.55%)
JBL : 127.30 (-0.29%)
WGO : 56.21 (-1.58%)
ASM.NA : 507.600 (-2.08%)
Esperion Therapeutics: Q1 Earnings Snapshot

Esperion Therapeutics: Q1 Earnings Snapshot

ESPR : 2.00 (-1.48%)
Esperion Therapeutics: Q4 Earnings Snapshot

Esperion Therapeutics: Q4 Earnings Snapshot

ESPR : 2.00 (-1.48%)
Esperion Therapeutics: Q3 Earnings Snapshot

Esperion Therapeutics: Q3 Earnings Snapshot

ESPR : 2.00 (-1.48%)
Esperion Therapeutics: Q2 Earnings Snapshot

Esperion Therapeutics: Q2 Earnings Snapshot

ESPR : 2.00 (-1.48%)
Esperion Therapeutics: Q1 Earnings Snapshot

Esperion Therapeutics: Q1 Earnings Snapshot

ESPR : 2.00 (-1.48%)

Business Summary

Esperion Therapeutics, Inc. is a pharmaceutical company focused on the development of oral lipid-management treatments for cardiovascular diseases caused by elevated levels of LDL-C (bad cholesterol).

See More

Key Turning Points

3rd Resistance Point 2.12
2nd Resistance Point 2.09
1st Resistance Point 2.04
Last Price 2.00
1st Support Level 1.96
2nd Support Level 1.93
3rd Support Level 1.88

See More

52-Week High 3.40
Fibonacci 61.8% 2.43
Fibonacci 50% 2.13
Last Price 2.00
Fibonacci 38.2% 1.83
52-Week Low 0.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar